Clinical Trials · NCT04535960
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- University Health Network, Toronto
- Enrollment
- 36
- Start date
- Jan 2019
- Locations
- 1 site, Canada
- Primary endpoint
- Proximal tubular natriuresis